Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling by Daniela Siegmund, Olena Zaitseva, Harald Wajant

Get full text

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies by Isabell Lang, Olena Zaitseva, Harald Wajant

Get full text

Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy by Olena Zaitseva, Annett Hoffmann, Christoph Otto, Harald Wajant

Get full text

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily by Olena Zaitseva, Mohamed Anany, Mohamed Anany, Harald Wajant, Isabell Lang

Get full text

Anti-Fn14 Antibody-Conjugated Nanoparticles Display Membrane TWEAK-Like Agonism by Ahmed Aido, Olena Zaitseva, Harald Wajant, Matej Buzgo, Aiva Simaite

Get full text

Genetically engineered IgG1 and nanobody oligomers acquire strong intrinsic CD40 agonism by Nienke Hesen, Mohamed Anany, Andre Freidel, Mediya Baker, Daniela Siegmund, Olena Zaitseva, Harald Wajant, Isabell Lang

Get full text

Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity by Olena Zaitseva, Annett Hoffmann, Margaretha Löst, Mohamed A. Anany, Mohamed A. Anany, Tengyu Zhang, Kirstin Kucka, Armin Wiegering, Christoph Otto, Harald Wajant

Get full text